
Genomics, mutations, and treatment options for Head & Neck Cancer
Studying genetic changes in cancer cells may be helpful in developing better treatments for head and neck cancer
Apr 27, 2021
Aug 17, 2023
Created With SupportAlex Fulton has been working in the wellness field for more than 20 years. She has written extensively about integrative medicine, herbalism, supplements and other topics related to holistic health. Alex also focuses on issues related to women's health, from menstruation to menopause. She has collaborated with physicians, midwives and functional medicine practitioners to promote natural approaches to health care for women. She has a BA in English from the University of Wisconsin-Madison.
Full BioLearn about our editorial policies
Studying genetic changes in cancer cells may be helpful in developing better treatments for head and neck cancer
Reviewed by Dr. Jennifer Grandis
Head and neck cancers account for about 4% of cancers in the U.S.
Head and neck cancers include cancers in the:
Risk factors for head and neck cancer include:
About 70% of oropharyngeal cancers, one type of head and neck cancer, are caused by HPV
(oropharynx = back of the throat, including the base of the tongue and tonsils)
Did you know? The HPV vaccine protects against the strains of HPV that cause oropharyngeal cancer.
Head and neck cancer and genetics
mutation = when genes inside a cell change
cancer genomics = comparing the DNA of cancer cells to normal cells
New approaches to treatment
Thanks to genomics, innovative treatments for head and neck cancer are being developed. These include:
immunotherapy = activating the immune system to attack cancer cells
Early detection is key to surviving head and neck cancer.
Look for:
This resource was created with support from Merck.